|
|
immune system development
|
GO:0002520 |
191 |
0.400
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
2 |
0.379
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.319
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.289
|
|
|
|
immune effector process
|
GO:0002252 |
23 |
0.275
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.261
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.250
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.228
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.210
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.200
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.198
|
|
|
|
eye development
|
GO:0001654 |
277 |
0.170
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.166
|
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.164
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.161
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.159
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.143
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.142
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.140
|
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
2 |
0.139
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.137
|
|
|
|
sensory system development
|
GO:0048880 |
76 |
0.136
|
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.134
|
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.129
|
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.128
|
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.126
|
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.124
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.122
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.120
|
|
|
|
nuclear transport
|
GO:0051169 |
4 |
0.118
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.118
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.118
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.112
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
97 |
0.111
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.110
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.110
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.108
|
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.108
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.107
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.107
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
97 |
0.106
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
3 |
0.105
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
2 |
0.104
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.102
|
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.101
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.099
|
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.099
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
3 |
0.098
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.096
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.094
|
|
|
|
gene expression
|
GO:0010467 |
252 |
0.092
|
|
|
|
regulation of immune system process
|
GO:0002682 |
34 |
0.088
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
15 |
0.085
|
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.084
|
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.084
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.083
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.082
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.081
|
|
|
|
viral process
|
GO:0016032 |
1 |
0.081
|
|
|
|
mediolateral intercalation
|
GO:0060031 |
3 |
0.079
|
|
|
|
negative regulation of mitosis
|
GO:0045839 |
3 |
0.078
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
4 |
0.077
|
|
|
|
regulation of immune response
|
GO:0050776 |
14 |
0.076
|
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.075
|
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.075
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
4 |
0.075
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
7 |
0.075
|
|
|
|
phagocytosis engulfment
|
GO:0006911 |
1 |
0.074
|
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
3 |
0.074
|
|
|
|
tyrosine phosphorylation of stat protein
|
GO:0007260 |
1 |
0.073
|
|
|
|
response to other organism
|
GO:0051707 |
97 |
0.073
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.072
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.071
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
3 |
0.070
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.069
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
4 |
0.069
|
|
|
|
regulation of wnt signaling pathway calcium modulating pathway
|
GO:0008591 |
3 |
0.068
|
|
|
|
multi organism cellular process
|
GO:0044764 |
2 |
0.068
|
|
|
|
liver development
|
GO:0001889 |
96 |
0.067
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.066
|
|
|
|
type i interferon biosynthetic process
|
GO:0045351 |
1 |
0.066
|
|
|
|
neuromast development
|
GO:0048884 |
46 |
0.066
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.065
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.065
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
5 |
0.065
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
3 |
0.064
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.064
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.064
|
|
|
|
cellular response to organic substance
|
GO:0071310 |
105 |
0.064
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.064
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.063
|
|
|
|
lateral line development
|
GO:0048882 |
66 |
0.062
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
11 |
0.062
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
4 |
0.061
|
|
|
|
cellular protein metabolic process
|
GO:0044267 |
129 |
0.060
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.060
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.060
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
3 |
0.059
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
1 |
0.059
|
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.057
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
17 |
0.057
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.057
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.055
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
4 |
0.055
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.055
|
|
|
|
adaptive immune response
|
GO:0002250 |
5 |
0.053
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.053
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.053
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
3 |
0.053
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
3 |
0.053
|
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.052
|
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.051
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.050
|
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.050
|
|
|
|
cellular component disassembly
|
GO:0022411 |
1 |
0.050
|
|
|
|
regulation of cell activation
|
GO:0050865 |
1 |
0.049
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.049
|
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.048
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
4 |
0.048
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
2 |
0.048
|
|
|
|
response to copper ion
|
GO:0046688 |
13 |
0.048
|
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.048
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.047
|
|
|
|
regulation of fibroblast growth factor receptor signaling pathway
|
GO:0040036 |
20 |
0.047
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
1 |
0.047
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
2 |
0.047
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
1 |
0.046
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
2 |
0.046
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
48 |
0.045
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
244 |
0.045
|
|
|
|
zymogen activation
|
GO:0031638 |
3 |
0.044
|
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.044
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
44 |
0.044
|
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.044
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
3 |
0.043
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
4 |
0.043
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.042
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
4 |
0.042
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
98 |
0.041
|
|
|
|
hepatocyte proliferation
|
GO:0072574 |
2 |
0.041
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.041
|
|
|
|
defense response
|
GO:0006952 |
47 |
0.041
|
|
|
|
regulation of endocrine process
|
GO:0044060 |
2 |
0.041
|
|
|
|
response to external stimulus
|
GO:0009605 |
264 |
0.040
|
|
|
|
optic placode formation involved in camera type eye formation
|
GO:0046619 |
3 |
0.040
|
|
|
|
determination of dorsal identity
|
GO:0048263 |
13 |
0.040
|
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.040
|
|
|
|
thrombocyte differentiation
|
GO:0002574 |
4 |
0.040
|
|
|
|
positive regulation of stress activated protein kinase signaling cascade
|
GO:0070304 |
3 |
0.039
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
4 |
0.039
|
|
|
|
diencephalon development
|
GO:0021536 |
58 |
0.039
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
4 |
0.039
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.039
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
1 |
0.038
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
2 |
0.038
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.038
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.038
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.038
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
20 |
0.037
|
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.036
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
96 |
0.036
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
4 |
0.035
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
29 |
0.035
|
|
|
|
determination of dorsal ventral asymmetry
|
GO:0048262 |
34 |
0.035
|
|
|
|
type i interferon production
|
GO:0032606 |
2 |
0.035
|
|
|
|
female sex differentiation
|
GO:0046660 |
4 |
0.035
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.035
|
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.035
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
1 |
0.035
|
|
|
|
regulation of anterior head development
|
GO:2000742 |
2 |
0.035
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.034
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
3 |
0.034
|
|
|
|
spindle assembly
|
GO:0051225 |
2 |
0.034
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.033
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
4 |
0.033
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
93 |
0.033
|
|
|
|
lateral line system development
|
GO:0048925 |
76 |
0.033
|
|
|
|
vacuolar transport
|
GO:0007034 |
2 |
0.033
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
3 |
0.032
|
|
|
|
endocrine process
|
GO:0050886 |
2 |
0.032
|
|
|
|
regulation of cell killing
|
GO:0031341 |
2 |
0.032
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
3 |
0.032
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.032
|
|
|
|
myofibril assembly
|
GO:0030239 |
48 |
0.032
|
|
|
|
tissue regeneration
|
GO:0042246 |
74 |
0.032
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
4 |
0.031
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.031
|
|
|
|
membrane invagination
|
GO:0010324 |
1 |
0.031
|
|
|
|
spinal cord development
|
GO:0021510 |
46 |
0.031
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
80 |
0.031
|
|
|
|
regulation of dna replication
|
GO:0006275 |
3 |
0.031
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
2 |
0.030
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
4 |
0.030
|
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.030
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
58 |
0.030
|
|
|
|
heart looping
|
GO:0001947 |
94 |
0.030
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.030
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.030
|
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.030
|
|
|
|
negative regulation of anterior neural cell fate commitment of the neural plate
|
GO:0022001 |
1 |
0.029
|
|
|
|
regulation of synapse organization
|
GO:0050807 |
3 |
0.029
|
|
|
|
response to corticosteroid
|
GO:0031960 |
1 |
0.029
|
|
|
|
midbrain hindbrain boundary development
|
GO:0030917 |
23 |
0.029
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
0 |
0.029
|
|
|
|
multicellular organism growth
|
GO:0035264 |
4 |
0.029
|
|
|
|
wnt signaling pathway involved in digestive tract morphogenesis
|
GO:0044333 |
4 |
0.029
|
|
|
|
hepatic duct development
|
GO:0061011 |
2 |
0.029
|
|
|
|
negative regulation of protein localization to nucleus
|
GO:1900181 |
2 |
0.029
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.029
|
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
4 |
0.028
|
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.028
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
0 |
0.028
|
|
|
|
epithelial cell proliferation involved in liver morphogenesis
|
GO:0072575 |
2 |
0.028
|
|
|
|
regulation of protein binding
|
GO:0043393 |
3 |
0.028
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.028
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
2 |
0.028
|
|
|
|
ear development
|
GO:0043583 |
127 |
0.028
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.027
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
3 |
0.027
|
|
|
|
regulation of wnt signaling pathway involved in digestive tract morphogenesis
|
GO:2000056 |
2 |
0.027
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.027
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
3 |
0.027
|
|
|
|
embryonic digestive tract morphogenesis
|
GO:0048557 |
3 |
0.027
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
2 |
0.027
|
|
|
|
mitochondrion organization
|
GO:0007005 |
4 |
0.027
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
2 |
0.027
|
|
|
|
establishment of spindle orientation
|
GO:0051294 |
10 |
0.027
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
1 |
0.027
|
|
|
|
protein import
|
GO:0017038 |
3 |
0.027
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.027
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
2 |
0.027
|
|
|
|
convergent extension involved in gastrulation
|
GO:0060027 |
71 |
0.027
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
8 |
0.026
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
1 |
0.026
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.026
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
1 |
0.026
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.026
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.026
|
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.025
|
|
|
|
antimicrobial humoral response
|
GO:0019730 |
2 |
0.025
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
3 |
0.025
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
9 |
0.025
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.025
|
|
|
|
forebrain regionalization
|
GO:0021871 |
4 |
0.025
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.025
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.024
|
|
|
|
complement activation
|
GO:0006956 |
3 |
0.024
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.024
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
1 |
0.024
|
|
|
|
neural tube patterning
|
GO:0021532 |
33 |
0.024
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.024
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
2 |
0.024
|
|
|
|
cellular response to starvation
|
GO:0009267 |
1 |
0.024
|
|
|
|
cellular response to stress
|
GO:0033554 |
62 |
0.024
|
|
|
|
response to cytokine
|
GO:0034097 |
7 |
0.024
|
|
|
|
activation of immune response
|
GO:0002253 |
9 |
0.024
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.024
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.024
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.023
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
3 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
13 |
0.023
|
|
|
|
lymph vessel development
|
GO:0001945 |
27 |
0.023
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
1 |
0.023
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
4 |
0.023
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.023
|
|
|
|
female gonad development
|
GO:0008585 |
4 |
0.023
|
|
|
|
dorsal convergence
|
GO:0060030 |
14 |
0.023
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
11 |
0.023
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
3 |
0.023
|
|
|
|
primitive hemopoiesis
|
GO:0060215 |
27 |
0.023
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.023
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
3 |
0.022
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
1 |
0.022
|
|
|
|
interferon beta production
|
GO:0032608 |
1 |
0.022
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
53 |
0.022
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
7 |
0.022
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
3 |
0.022
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.022
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
1 |
0.022
|
|
|
|
death
|
GO:0016265 |
121 |
0.022
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
1 |
0.021
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
1 |
0.021
|
|
|
|
heart valve formation
|
GO:0003188 |
4 |
0.021
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
94 |
0.021
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
3 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
110 |
0.021
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
2 |
0.021
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
1 |
0.021
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
57 |
0.021
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
2 |
0.021
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.021
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
4 |
0.021
|
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.021
|
|
|
|
anterior head development
|
GO:0097065 |
2 |
0.020
|
|
|
|
endoderm development
|
GO:0007492 |
49 |
0.020
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
1 |
0.020
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
56 |
0.020
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
5 |
0.020
|
|
|
|
optic placode formation
|
GO:0001743 |
4 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
91 |
0.020
|
|
|
|
protein dephosphorylation
|
GO:0006470 |
3 |
0.020
|
|
|
|
membrane fusion
|
GO:0061025 |
2 |
0.020
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.020
|
|
|
|
cell death
|
GO:0008219 |
121 |
0.020
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
22 |
0.020
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
1 |
0.020
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
51 |
0.020
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
31 |
0.020
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
2 |
0.020
|
|
|
|
positive regulation of epithelial cell differentiation
|
GO:0030858 |
2 |
0.020
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
1 |
0.020
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
19 |
0.020
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.020
|
|
|
|
notochord development
|
GO:0030903 |
54 |
0.019
|
|
|
|
brain development
|
GO:0007420 |
293 |
0.019
|
|
|
|
vasculogenesis
|
GO:0001570 |
41 |
0.019
|
|
|
|
aging
|
GO:0007568 |
2 |
0.019
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.019
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
3 |
0.019
|
|
|
|
immune response
|
GO:0006955 |
28 |
0.019
|
|
|
|
axonogenesis
|
GO:0007409 |
152 |
0.019
|
|
|
|
locomotor rhythm
|
GO:0045475 |
3 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
23 |
0.019
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
1 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
222 |
0.019
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
3 |
0.019
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
48 |
0.019
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
4 |
0.019
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
1 |
0.019
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.019
|
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
23 |
0.019
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
1 |
0.019
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.019
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.018
|
|
|
|
response to virus
|
GO:0009615 |
21 |
0.018
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
2 |
0.018
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
1 |
0.018
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.018
|
|
|
|
axon extension
|
GO:0048675 |
45 |
0.018
|
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.018
|
|
|
|
fin regeneration
|
GO:0031101 |
51 |
0.018
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
2 |
0.018
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
1 |
0.018
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
55 |
0.018
|
|
|
|
er to golgi vesicle mediated transport
|
GO:0006888 |
1 |
0.018
|
|
|
|
neuromuscular synaptic transmission
|
GO:0007274 |
2 |
0.018
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
3 |
0.018
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
2 |
0.018
|
|
|
|
protein modification process
|
GO:0036211 |
100 |
0.017
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
2 |
0.017
|
|
|
|
cortical actin cytoskeleton organization
|
GO:0030866 |
1 |
0.017
|
|
|
|
protein acylation
|
GO:0043543 |
3 |
0.017
|
|
|
|
cation transport
|
GO:0006812 |
81 |
0.017
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
7 |
0.017
|
|
|
|
defense response to other organism
|
GO:0098542 |
33 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.017
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
2 |
0.017
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
2 |
0.017
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
54 |
0.017
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
42 |
0.017
|
|
|
|
habenula development
|
GO:0021986 |
9 |
0.017
|
|
|
|
cytokine production
|
GO:0001816 |
4 |
0.017
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.017
|
|
|
|
protein import into nucleus
|
GO:0006606 |
3 |
0.017
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
4 |
0.017
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
55 |
0.017
|
|
|
|
cell aging
|
GO:0007569 |
2 |
0.017
|
|
|
|
endoplasmic reticulum unfolded protein response
|
GO:0030968 |
2 |
0.017
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
2 |
0.017
|
|
|
|
rna modification
|
GO:0009451 |
2 |
0.017
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.017
|
|
|
|
appendage development
|
GO:0048736 |
80 |
0.016
|
|
|
|
spinal cord anterior posterior patterning
|
GO:0021512 |
1 |
0.016
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
4 |
0.016
|
|
|
|
protein complex disassembly
|
GO:0043241 |
1 |
0.016
|
|
|
|
activation of jun kinase activity
|
GO:0007257 |
2 |
0.016
|
|
|
|
cellular response to dsrna
|
GO:0071359 |
1 |
0.016
|
|
|
|
positive regulation of metabolic process
|
GO:0009893 |
108 |
0.016
|
|
|
|
specification of organ identity
|
GO:0010092 |
2 |
0.016
|
|
|
|
regulation of dendrite morphogenesis
|
GO:0048814 |
3 |
0.016
|
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.016
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
1 |
0.016
|
|
|
|
single organism membrane fusion
|
GO:0044801 |
2 |
0.016
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
35 |
0.016
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
1 |
0.016
|
|
|
|
regulation of axonogenesis
|
GO:0050770 |
32 |
0.016
|
|
|
|
steroid hormone secretion
|
GO:0035929 |
1 |
0.016
|
|
|
|
gland development
|
GO:0048732 |
143 |
0.016
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
204 |
0.016
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
2 |
0.016
|
|
|
|
cell junction maintenance
|
GO:0034331 |
2 |
0.016
|
|
|
|
forebrain development
|
GO:0030900 |
96 |
0.016
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.016
|
|
|
|
neuron projection extension
|
GO:1990138 |
45 |
0.016
|
|
|
|
negative regulation of translation
|
GO:0017148 |
1 |
0.016
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
1 |
0.016
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
1 |
0.016
|
|
|
|
epithalamus development
|
GO:0021538 |
10 |
0.016
|
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.016
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
53 |
0.016
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
2 |
0.016
|
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.016
|
|
|
|
exocytosis
|
GO:0006887 |
1 |
0.016
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
1 |
0.016
|
|
|
|
cellular protein modification process
|
GO:0006464 |
100 |
0.016
|
|
|
|
macromolecule modification
|
GO:0043412 |
111 |
0.016
|
|
|
|
regulation of growth
|
GO:0040008 |
42 |
0.016
|
|
|
|
protein acetylation
|
GO:0006473 |
2 |
0.016
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
4 |
0.016
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
51 |
0.016
|
|
|
|
cell cycle arrest
|
GO:0007050 |
1 |
0.015
|
|
|
|
swim bladder development
|
GO:0048794 |
19 |
0.015
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
3 |
0.015
|
|
|
|
regulation of tyrosine phosphorylation of stat protein
|
GO:0042509 |
1 |
0.015
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
2 |
0.015
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.015
|
|
|
|
endocardial cushion development
|
GO:0003197 |
6 |
0.015
|
|
|
|
gtp catabolic process
|
GO:0006184 |
2 |
0.015
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.015
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
1 |
0.015
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
3 |
0.015
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
2 |
0.015
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
87 |
0.015
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.015
|
|
|
|
cytokinesis
|
GO:0000910 |
3 |
0.015
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
1 |
0.015
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
3 |
0.015
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
2 |
0.015
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
1 |
0.015
|
|
|
|
autophagy
|
GO:0006914 |
4 |
0.014
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
25 |
0.014
|
|
|
|
synaptic vesicle recycling
|
GO:0036465 |
1 |
0.014
|
|
|
|
neuron projection development
|
GO:0031175 |
180 |
0.014
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
2 |
0.014
|
|
|
|
response to wounding
|
GO:0009611 |
116 |
0.014
|
|
|
|
entrainment of circadian clock by photoperiod
|
GO:0043153 |
1 |
0.014
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
3 |
0.014
|
|
|
|
maturation of ssu rrna
|
GO:0030490 |
1 |
0.014
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
3 |
0.014
|
|
|
|
determination of left right asymmetry in diencephalon
|
GO:0035462 |
4 |
0.014
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
1 |
0.014
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
3 |
0.014
|
|
|
|
negative chemotaxis
|
GO:0050919 |
1 |
0.014
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
2 |
0.014
|
|
|
|
determination of ventral identity
|
GO:0048264 |
21 |
0.014
|
|
|
|
b cell differentiation
|
GO:0030183 |
1 |
0.014
|
|
|
|
myeloid cell development
|
GO:0061515 |
32 |
0.014
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
3 |
0.014
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
2 |
0.014
|
|
|
|
somatic muscle development
|
GO:0007525 |
4 |
0.014
|
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
56 |
0.014
|
|
|
|
regulation of steroid hormone secretion
|
GO:2000831 |
1 |
0.014
|
|
|
|
regulation of skeletal muscle tissue development
|
GO:0048641 |
4 |
0.014
|
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.014
|
|
|
|
positive regulation of muscle organ development
|
GO:0048636 |
1 |
0.014
|
|
|
|
cardiac atrium development
|
GO:0003230 |
4 |
0.014
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
2 |
0.013
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.013
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
2 |
0.013
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
2 |
0.013
|
|
|
|
heart jogging
|
GO:0003146 |
40 |
0.013
|
|
|
|
negative regulation of cell division
|
GO:0051782 |
4 |
0.013
|
|
|
|
endosomal transport
|
GO:0016197 |
2 |
0.013
|
|
|
|
cilium organization
|
GO:0044782 |
71 |
0.013
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
2 |
0.013
|
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
1 |
0.013
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
56 |
0.013
|
|
|
|
p38mapk cascade
|
GO:0038066 |
1 |
0.013
|
|
|
|
gall bladder development
|
GO:0061010 |
1 |
0.013
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
3 |
0.013
|
|
|
|
eye morphogenesis
|
GO:0048592 |
144 |
0.013
|
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.013
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.013
|
|
|
|
aorta development
|
GO:0035904 |
4 |
0.013
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
2 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
56 |
0.013
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
1 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.013
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
1 |
0.013
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
30 |
0.013
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
1 |
0.013
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
1 |
0.013
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.013
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
1 |
0.013
|
|
|
|
protein homooligomerization
|
GO:0051260 |
3 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.013
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.013
|
|
|
|
cell fate commitment
|
GO:0045165 |
99 |
0.013
|
|
|
|
collagen metabolic process
|
GO:0032963 |
2 |
0.012
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
3 |
0.012
|
|
